| 54072-4 |
Hemoglobin A/Hemoglobin.total |
MFr |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Hemoglobin A/Hemoglobin.total in DBS |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
54072-4 |
|
|
|
|
Observation |
|
|
|
0 |
Hgb A MFr DBS |
|
|
|
N |
|
Blood; DBS; Dried blood spot; Filter paper; FP; Haemoglobin; Hb; HbA; HEMATOLOGY/CELL COUNTS; Hgb; Hgb A; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood |
2.61 |
2.26 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 54073-2 |
Hemoglobin C/Hemoglobin.total |
MFr |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Hemoglobin C/Hemoglobin.total in DBS |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
54073-2 |
|
|
|
|
Observation |
|
|
|
0 |
Hgb C MFr DBS |
|
|
|
N |
|
Blood; DBS; Dried blood spot; Filter paper; FP; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb C; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood |
2.61 |
2.26 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 54074-0 |
Hemoglobin F/Hemoglobin.total |
MFr |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Hemoglobin F/Hemoglobin.total in DBS |
|
MIN |
DefinitionDescription |
|
|
% |
|
|
|
|
|
|
HEM/BC |
|
54074-0 |
|
|
|
|
Observation |
|
|
|
0 |
Hgb F MFr DBS |
|
|
|
N |
|
Blood; DBS; Dried blood spot; Fetal hemoglobin; Filter paper; FP; Haemoglobin; Hb; HbF; HEMATOLOGY/CELL COUNTS; Hgb; Hgb F; Mass Fraction; Percent; Point in time; QNT; Quan; Quant; Quantitative; Random; Tot; Totl; WB; Whole blood |
2.61 |
2.26 |
|
|
|
|
|
|
|
% |
|
|
|
0 |
| 54075-7 |
Endocrine newborn screening panel (SI units) |
- |
Bld.dot |
Pt |
- |
|
|
ACTIVE |
Endocrine newborn screening panel (SI units) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
54075-7 |
|
|
|
|
Order |
|
|
|
0 |
NB pnl Endocrine SI DBS |
|
|
|
N |
|
Asympt; Asymptomatic; Blood; Chemistry; DBS; Dried blood spot; Endocrine; Endocrinology; Filter paper; FP; Gyn; Gynecology; NB pnl Endocrine; NB pnl Endocrine SI; NB Screen Pnl; NBS; New born; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; WB; Whole blood |
2.4 |
2.26 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 54076-5 |
Endocrine newborn screening panel |
- |
Bld.dot |
Pt |
- |
|
|
ACTIVE |
Endocrine newborn screening panel |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
54076-5 |
|
|
|
|
Order |
|
|
|
0 |
NB pnl Endocrine DBS |
|
|
|
N |
|
Asympt; Asymptomatic; Blood; Chemistry; DBS; Dried blood spot; Endocrine; Endocrinology; Filter paper; FP; Gyn; Gynecology; NB pnl Endocrine; NB Screen Pnl; NBS; New born; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; WB; Whole blood |
2.77 |
2.26 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 54077-3 |
Thyroid newborn screening panel (SI units) |
- |
Bld.dot |
Pt |
- |
|
|
ACTIVE |
Thyroid newborn screening panel (SI units) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
54077-3 |
|
|
|
|
Order |
|
|
|
0 |
NB pnl Thyroid SI DBS |
|
|
|
N |
|
Asympt; Asymptomatic; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Gyn; Gynecology; NB pnl Thyroid; NB pnl Thyroid SI; NB Screen Pnl; NBS; New born; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; WB; Whole blood |
2.4 |
2.26 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 54078-1 |
Cystic fibrosis newborn screening panel |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
Cystic fibrosis newborn screening panel |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
54078-1 |
|
|
|
|
Order |
|
|
|
0 |
NB pnl CF Patient |
|
|
|
N |
|
Asympt; Asymptomatic; CF; Chemistry; Cystic fibr; Genetics; Gyn; Gynecology; Heredity; Heritable; Inherited; NB pnl CF; NB Screen Pnl; NBS; New born; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; UniversalLabOrders |
2.77 |
2.26 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 54079-9 |
Galactosemia newborn screening panel |
- |
Bld.dot |
Pt |
- |
|
|
ACTIVE |
Galactosemia newborn screening panel |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
54079-9 |
|
|
|
|
Order |
|
|
|
0 |
NB pnl Galactosemia DBS |
|
|
|
N |
|
Asympt; Asymptomatic; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Gyn; Gynecology; NB pnl Galactosemia; NB Screen Pnl; NBS; New born; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; WB; Whole blood |
2.77 |
2.26 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 5408-0 |
Yersinia enterocolitica O:8 Ab |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Yersinia enterocolitica O:8 Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
5408-0 |
|
|
|
|
Both |
|
|
|
0 |
Y entero O:8 Ab Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Y entero O:8; Y enterocol; Y enterocolitica |
2.73 |
1 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
Changed O8 to O:8 based on currently recommended nomenclature for the Yersinia enterocolitica serogroups [PMID: 22019131] |
0 |
| 54080-7 |
Galactosemia newborn screening panel (SI units) |
- |
Bld.dot |
Pt |
- |
|
|
ACTIVE |
Galactosemia newborn screening panel (SI units) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
54080-7 |
|
|
|
|
Order |
|
|
|
0 |
NB pnl Galactosemia SI DBS |
|
|
|
N |
|
Asympt; Asymptomatic; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Gyn; Gynecology; NB pnl Galactosemia; NB pnl Galactosemia SI; NB Screen Pnl; NBS; New born; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; WB; Whole blood |
2.4 |
2.26 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 54081-5 |
Hemoglobinopathies newborn screening panel |
- |
Bld.dot |
Pt |
- |
|
|
ACTIVE |
Hemoglobinopathies newborn screening panel |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.HEM/BC |
|
54081-5 |
|
|
|
|
Order |
|
|
|
0 |
NB pnl Hemoglobinopathies DBS |
|
|
|
N |
|
Asympt; Asymptomatic; Blood; DBS; Dried blood spot; Filter paper; FP; Gyn; Gynecology; HEMATOLOGY/CELL COUNTS; NB pnl Hemoglobinopathies; NB Screen Pnl; NBS; New born; OB; ObGyn; Obstetrics; Pan; PANEL.HEMATOLOGY& CELL COUNTS; Panl; Pnl; Point in time; Random; Scn; WB; Whole blood |
2.77 |
2.26 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 54082-3 |
Infectious diseases newborn screening panel |
- |
Bld.dot |
Pt |
- |
|
|
ACTIVE |
Infectious diseases newborn screening panel |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
54082-3 |
|
|
|
|
Order |
|
|
|
0 |
NB pnl Infectious diseases DBS |
|
|
|
N |
|
Asympt; Asymptomatic; Blood; DBS; Dried blood spot; Filter paper; FP; ID; Infectious Disease; InfectiousDisease; Microbiology; NB pnl Infectious diseases; NB Screen Pnl; NBS; New born; Pan; PANEL.MICROBIOLOGY; Panl; Pnl; Point in time; Random; Scn; WB; Whole blood |
2.77 |
2.26 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 54083-1 |
CFTR gene targeted mutation analysis |
Prid |
Bld.dot |
Pt |
Nom |
Molgen |
|
ACTIVE |
CFTR gene mutations found [Identifier] in DBS by Molecular genetics method Nominal |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
54083-1 |
|
Molgen |
|
|
Both |
|
|
|
0 |
CFTR Mut Anl DBS |
|
|
|
N |
|
ABC35; ABCC7; Blood; CBAVD; CF; CFA; CFTR/MRP; Cystic fibrosis transmembrane conductance regulator; cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7); DBS; dJ760C5.1; Dried blood spot; Filter paper; FP; Genetics; Heredity; Heritable; Identity or presence; Inherited; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; MRP7; Mut; Mut Anl; Mutations; Nominal; PCR; Point in time; Random; TNR-CFTR; WB; Whole blood |
2.73 |
2.26 |
|
|
|
|
|
|
|
|
|
|
Based on LOINC Committee review (June 2016), "targeted" was added to the Component to clarify that this test is looking for a specific set of mutations as described in the LOINC User Guide under the Molecular Genetics section. |
0 |
| 54084-9 |
Galactose |
MCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Galactose [Mass/volume] in DBS |
|
MIN |
DefinitionDescription |
|
|
mg/dL |
|
|
|
|
|
|
CHEM |
|
54084-9 |
|
|
|
|
Both |
|
|
|
0 |
Galactose DBS-mCnc |
|
|
|
N |
|
Blood; Cerebrose; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; WB; Whole blood |
2.73 |
2.26 |
|
|
|
|
|
|
|
mg/dL |
|
|
|
0 |
| 54085-6 |
Galactose |
SCnc |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Galactose [Moles/volume] in DBS |
|
MIN |
DefinitionDescription |
|
|
mmol/L |
|
|
|
|
|
|
CHEM |
|
54085-6 |
|
|
|
|
Both |
|
|
|
0 |
Galactose DBS-sCnc |
|
|
|
N |
|
Blood; Cerebrose; Chemistry; DBS; Dried blood spot; Filter paper; FP; Level; Point in time; QNT; Quan; Quant; Quantitative; Random; Substance concentration; WB; Whole blood |
2.73 |
2.26 |
|
|
|
|
|
|
|
mmol/L |
|
|
|
0 |
| 54086-4 |
HIV 1+2 Ab.IgG |
PrThr |
Bld.dot |
Pt |
Ord |
|
|
ACTIVE |
HIV 1+2 IgG Ab [Presence] in DBS |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
54086-4 |
|
|
|
|
Both |
|
|
|
0 |
HIV1+2 IgG DBS Ql |
|
|
|
N |
|
ABS; Aby; AIDS; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; DBS; Dried blood spot; Filter paper; FP; HIV 1 & 2; HIV 1 and 2 Ab; HIV type 1; HIV type I; HIV1; HIV1+2; Human immunodeficiency virus; i; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; WB; Whole blood |
2.61 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 54087-2 |
Toxoplasma gondii Ab.IgG |
PrThr |
Bld.dot |
Pt |
Ord |
|
|
ACTIVE |
Toxoplasma gondii IgG Ab [Presence] in DBS |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
54087-2 |
|
|
|
|
Both |
|
|
|
0 |
T gondii IgG DBS Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; DBS; Dried blood spot; Filter paper; FP; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; T gondii; Toxo; Toxoplasmosis; WB; Whole blood |
2.61 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 54088-0 |
Toxoplasma gondii Ab.IgM |
PrThr |
Bld.dot |
Pt |
Ord |
|
|
ACTIVE |
Toxoplasma gondii IgM Ab [Presence] in DBS |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
54088-0 |
|
|
|
|
Both |
|
|
|
0 |
T gondii IgM DBS Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Blood; DBS; Dried blood spot; Filter paper; FP; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; T gondii; Toxo; Toxoplasmosis; WB; Whole blood |
2.61 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 54089-8 |
Newborn screening panel |
- |
^Patient |
Pt |
- |
AHIC |
|
ACTIVE |
Newborn screening panel American Health Information Community (AHIC) |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
54089-8 |
|
AHIC |
|
|
Order |
|
|
|
0 |
NB Screen Pnl Patient AHIC |
|
|
|
N |
|
Asympt; Asymptomatic; Chemistry; NB Screen Pnl; NBS; New born; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; UniversalLabOrders |
2.77 |
2.26 |
|
Panel |
|
|
|
|
|
|
|
|
|
28 |
| 5409-8 |
Yersinia enterocolitica O:9 Ab |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Yersinia enterocolitica O:9 Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
5409-8 |
|
|
|
|
Both |
|
|
|
0 |
Y entero O:9 Ab Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Y entero O:9; Y enterocol; Y enterocolitica |
2.73 |
1 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
Changed zero to O in component; Changed O9 to O:9 based on currently recommended nomenclature for the Yersinia enterocolitica serogroups [PMID: 22019131] |
0 |
| 54090-6 |
Thyroid newborn screening panel |
- |
Bld.dot |
Pt |
- |
|
|
ACTIVE |
Thyroid newborn screening panel |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.CHEM |
|
54090-6 |
|
|
|
|
Order |
|
|
|
0 |
NB pnl Thyroid DBS |
|
|
|
N |
|
Asympt; Asymptomatic; Blood; Chemistry; DBS; Dried blood spot; Filter paper; FP; Gyn; Gynecology; NB pnl Thyroid; NB Screen Pnl; NBS; New born; OB; ObGyn; Obstetrics; Pan; PANEL.CHEMISTRY; Panl; Pnl; Point in time; Random; Scn; WB; Whole blood |
2.77 |
2.26 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
| 54091-4 |
Rubella virus RNA |
PrThr |
XXX |
Pt |
Ord |
Probe.amp.tar |
|
ACTIVE |
Rubella virus RNA [Presence] in Specimen by NAA with probe detection |
|
MIN |
DefinitionDescription |
|
|
|
Rubella virus RNA detected; No Rubella virus RNA detected; Equivocal; Indeterminate |
|
|
|
|
|
MICRO |
|
54091-4 |
|
Probe.amp.tar |
|
|
Both |
|
|
|
0 |
RUBV RNA Spec Ql NAA+probe |
|
|
|
N |
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Congenital rubella syndrome; DNA NUCLEIC ACID PROBE; DNA probe; German measles; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; Misc; Miscellaneous; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; Other; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; RUBV; Screen; SDA; Spec; Strand Displacement Amplification; TMA; To be specified in another part of the message; Transcription mediated amplification; Unspecified |
2.73 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 54092-2 |
Citrulline/Arginine |
SRto |
Bld.dot |
Pt |
Qn |
|
|
ACTIVE |
Citrulline/Arginine [Molar ratio] in DBS |
|
MIN |
DefinitionDescription |
|
|
Ratio |
|
|
|
|
|
|
CHEM |
|
54092-2 |
|
|
|
|
Observation |
|
|
|
0 |
Citrulline/Arginine DBS-sRto |
|
|
|
N |
|
Arg; Blood; Chemistry; CIT; Citr; DBS; Dried blood spot; Filter paper; FP; Point in time; QNT; Quan; Quant; Quantitative; Random; Scrto; Substance concentration ratio; Substance ratio; WB; Whole blood |
2.73 |
2.26 |
|
|
|
|
|
|
|
{Ratio} |
|
|
|
0 |
| 54093-0 |
Pesticides |
PrThr |
Gast fld |
Pt |
Ord |
Screen |
|
ACTIVE |
Pesticides [Presence] in Gastric fluid by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
54093-0 |
|
Screen |
|
|
Both |
|
|
|
0 |
Pesticides Gast Ql Scn |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; GAST; Gastric contents; Gastric fluid; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 54094-8 |
Triage note |
Find |
Emergency department |
Pt |
Doc |
{Role} |
|
ACTIVE |
Emergency department Triage note |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DOC.ONTOLOGY |
|
54094-8 |
|
{Role} |
|
|
Both |
|
|
|
0 |
ED Triage note |
|
|
|
N |
|
DOC.ONT; Document; ED; Encounter; Evaluation and management; Evaluation and management note; Finding; Findings; notes; Point in time; Random; Visit note |
2.73 |
2.26 |
|
|
|
|
|
|
|
|
|
|
Added method of {Provider} to harmonize with existing similar terms and current LOINC Document Ontology model. Moved term to DOC.CLINRPT Class to be included in the Document Ontology.; Based on Clinical LOINC Committee decision during the September 2014 meeting, {Provider} was changed to {Author Type} to emphasize a greater breadth of potential document authors. At the September 2015 Clinical LOINC Committee meeting, the Committee decided to change {Author Type} to {Role} to align with the 'Role' axis name in the LOINC Document Ontology. |
0 |
